6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine

C21H21F3N8 — CID 166495257

IUPAC6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine
SMILESCN(C)C[C@@H](c1ccc(C(F)(F)F)cc1)n1cc(-c2ncnc(N)c2-c2cn[nH]c2)cn1
InChIInChI=1S/C21H21F3N8/c1-31(2)11-17(13-3-5-16(6-4-13)21(22,23)24)32-10-15(9-30-32)19-18(14-7-28-29-8-14)20(25)27-12-26-19/h3-10,12,17H,11H2,1-2H3,(H,28,29)(H2,25,26,27)/t17-/m0/s1
InChIKeyIYPWLNLJFVVLTL-KRWDZBQOSA-N
MW442.45 g/mol
LogP3.48
Rot. Bonds6

About 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine

6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine (PubChem CID 166495257) has the molecular formula C21H21F3N8 and a molecular weight of 442.45 g/mol. Its IUPAC name is 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine.

Molecular Properties

Compound Name6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine
PubChem CID166495257
Molecular FormulaC21H21F3N8
Molecular Weight442.45 g/mol
Exact Mass442.18
IUPAC Name6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine
SMILESCN(C)C[C@@H](c1ccc(C(F)(F)F)cc1)n1cc(-c2ncnc(N)c2-c2cn[nH]c2)cn1
InChIInChI=1S/C21H21F3N8/c1-31(2)11-17(13-3-5-16(6-4-13)21(22,23)24)32-10-15(9-30-32)19-18(14-7-28-29-8-14)20(25)27-12-26-19/h3-10,12,17H,11H2,1-2H3,(H,28,29)(H2,25,26,27)/t17-/m0/s1
InChIKeyIYPWLNLJFVVLTL-KRWDZBQOSA-N
XLogP3.48
TPSA101.54 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500442.45
LogP ≤ 53.48
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine?
The IUPAC name of 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine (CID 166495257) is 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine.
What is the SMILES notation for 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine?
The canonical SMILES for 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine is CN(C)C[C@@H](c1ccc(C(F)(F)F)cc1)n1cc(-c2ncnc(N)c2-c2cn[nH]c2)cn1.
What is the InChIKey of 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine?
The InChIKey is IYPWLNLJFVVLTL-KRWDZBQOSA-N. The full InChI is InChI=1S/C21H21F3N8/c1-31(2)11-17(13-3-5-16(6-4-13)21(22,23)24)32-10-15(9-30-32)19-18(14-7-28-29-8-14)20(25)27-12-26-19/h3-10,12,17H,11H2,1-2H3,(H,28,29)(H2,25,26,27)/t17-/m0/s1.
What are the key properties of 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine?
6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine has a molecular weight of 442.45 g/mol, XLogP of 3.48, 6 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[1-[(1R)-2-(dimethylamino)-1-[4-(trifluoromethyl)phenyl]ethyl]pyrazol-4-yl]-5-(1H-pyrazol-4-yl)pyrimidin-4-amine is sourced from PubChem (CID 166495257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).